首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus.
【24h】

Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus.

机译:用基于S蛋白的ELISA检测冠状病毒HKU1的血清阳性率,并针对病毒性刺突假型病毒进行中和测定。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Human coronavirus HKU1 (HCoV-HKU1) is a recently identified coronavirus with a global distribution and known to cause mainly respiratory infections. OBJECTIVES: To investigate the seroepidemiology of HKU1 infections in our local population. STUDY DESIGN: An ELISA-based IgG antibody detection assay using recombinant HCoV-HKU1 nucleocapsid and spike (S) proteins (genotype A) were developed for the diagnosis of CoV-HKU1 infections, Additionally, a neutralization antibody assay using the HCoV-HKU1 pseudotyped virus was developed to detect the presence of neutralizing antibodies in serum with antibody positivity in an S protein-based ELISA. RESULTS: Results of the recombinant S protein-based ELISA were validated with Western blot, immunofluorescence analysis and flow cytometry. The coupled results demonstrated good correlation with Spearmen's coefficient of 0.94. Seroepidemiological study in a local hospital-based setting using this newly developed ELISA showed steadily increasing HCoV-HKU1 seroprevalence in childhood and early adulthood, from 0% in the age group of <10 years old to a plateau of 21.6% in the age group of 31-40 years old. CONCLUSIONS: Our study demonstrated the usefulness of the S-based ELISA which could be applied to future epidemiological studies of HCoV-HKU1 in other localities.
机译:背景:人类冠状病毒HKU1(HCoV-HKU1)是最近发现的具有全球分布的冠状病毒,已知主要引起呼吸道感染。目的:调查当地人群中HKU1感染的血清流行病学。研究设计:使用重组HCoV-HKU1核衣壳和刺突(S)蛋白(基因型A)开发了基于ELISA的IgG抗体检测试剂,用于诊断CoV-HKU1感染,此外,还使用了假型的HCoV-HKU1进行中和抗体检测在基于S蛋白的ELISA中开发了可检测到血清中具有抗体阳性的中和抗体的病毒。结果:基于Western blot,免疫荧光分析和流式细胞仪验证了基于重组S蛋白的ELISA结果。耦合结果表明,Spearmen系数为0.94,具有良好的相关性。使用这种新开发的ELISA在当地医院进行的血清流行病学研究显示,儿童和成年早期的HCoV-HKU1血清阳性率稳定上升,从<10岁年龄段的0%上升到21岁年龄段的21.6%的平稳期。 31-40岁。结论:我们的研究证明了基于S的ELISA的有用性,该方法可用于未来HCoV-HKU1在其他地区的流行病学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号